Table 3 Success status and antiglaucoma medications in study and control groupsa
Baseline | Last follow-up | |||||
|---|---|---|---|---|---|---|
Study Group | Control Group | P-value** | Study Group | Control Group | P-value** | |
Success status | 0.50 | 0.28 | ||||
Absolute success | 15 (78.9%) | 16 (84.2%) | 6 (31.6%) | 10 (52.6%) | ||
(maintain status) | (5/15) | (8/16) | ||||
(failed) | (5/15) | (6/16) | ||||
Qualified success | 4 (21.1%) | 3 (15.8%) | 7 (36.8%) | 3 (15.8%) | ||
(maintain status) | (2/4) | (1/3) | ||||
(failed) | (1/4) | Zero | ||||
Failure | – | – | 6 (31.6%) | 6 (31.6%) | ||
Medications | ||||||
One or None | 17 (89.5%) | 19 (100%) | 0.24 | 10 (52.6%) | 15 (78.9%) | 0.09 |
Two or more | 2 (10.5%) | Zero | 9 (47.4%) | 4 (21.1%) | ||